Cancer Communications | Home page

Cancer Communications | Home page



Cancer Communications

Articles

• Recent
• Most accessed
• Collections

1. Content Type:Original Article

     |  28 May 2019

   Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

   Authors:Ji-Yeon Kim, Seri Park, Seock-Ah Im, Sung-Bae Kim, Joohyuk Sohn, Keun Seok Lee, Yee Soo Chae, Ki Hyeong Lee, Jee Hyun Kim, Young-Hyuck Im, Tae-Yong Kim, Kyung-Hun Lee, Jin-Hee Ahn, Gun Min Kim, In Hae Park, Soo Jung Lee…
2. Content Type:Original Article

     |  24 May 2019

   CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial

   Authors:Yuankai Shi, Jin Li, Jianming Xu, Yan Sun, Liwei Wang, Ying Cheng, Wei Liu, Guoping Sun, Yigui Chen, Li Bai, Yiping Zhang, Xiaohui He, Yi Luo, Zhehai Wang, Yunpeng Liu, Qiang Yao…
3. Content Type:Letter To The Editor

     |  14 May 2019

   Is cancer-related death associated with circadian rhythm?

   Authors:Shing Fung Lee and Miguel Angel Luque-Fernandez
4. Content Type:Original Article

     |  8 May 2019

   The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

   Authors:Zhi-Qiang Wang, Fei Zhang, Ting Deng, Le Zhang, Fen Feng, Feng-Hua Wang, Wei Wang, De-Shen Wang, Hui-Yan Luo, Rui-Hua Xu, Yi Ba and Yu-Hong Li
5. Content Type:Original Article

     |  8 May 2019

   Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?

   Authors:Jin Wang, Hailin Tang, Xing Li, Cailu Song, Zhenchong Xiong, Xi Wang, Xiaoming Xie and Jun Tang